France moves to suspend Vitamin D supplement after baby dies

January 4, 2017

France has moved to suspend sales of a vitamin D medication following the death of a baby who suffocated after being given the liquid supplement, health authorities said Wednesday.

France's ANSM agency that oversees the safety of medicines and health products said it had taken the measure "as a precaution" after investigations showed "a probable link between the death and the administration of Uvesterol D".

The 10-day-old baby died on December 21 after being given Uvesterol D, a popular brand of drops prescribed for children suffering from vitamin D deficiency. The supplement is only available in France.

ANSM has previously issued warnings about how the supplement is administered—with a pipette—following cases of respiratory problems, especially among premature babies and newborns.

The agency said Wednesday it would suspend the marketing of Uvesterol D in the coming days.

Uvesterol D is made by Crinex, a French pharmaceutical company.

Health Minister Marisol Touraine said it was "the specific way the product is administered that presents risks", rather than the vitamin itself.

In advance of a definitive decision from ANSM, she called on parents, "as a precautionary measure, to no longer administer Uvesterol D to their children".

"I want to reassure parents who have given vitamin D, in whatever form, to their children: they are safe," she said in a statement Wednesday, adding that "only Uvesterol D is concerned" by this procedure.

In an email on December 30 and seen by AFP, ANSM said the baby died at home from "cardio-respiratory arrest" after receiving a dose of Uvesterol D.

The child showed "signs of suffocation" directly after receiving the product, two hours after breastfeeding, the ANSM wrote.

Uvesterol D comes in a vial from which the dose is extracted with the pipette.

In 2006 and again in 2013, the ANSM had issued precautions to be taken when administering the supplement, to avoid babies choking on the fluid.

Parents were advised, among other things, to give it to babies "drop by drop".

Explore further: France says 'isolated' lapse in IV bags behind baby deaths

Related Stories

France says 'isolated' lapse in IV bags behind baby deaths

January 24, 2014
An "isolated" lapse in the manufacture of intravenous nutrient bags likely caused the deaths of up to five babies at a French hospital, the health minister said Friday.

France to tighten up drug trial rules after fatal incident

May 23, 2016
France's health minister presented a plan on Monday to tighten the rules regarding human drug trials following an experimental test that killed a volunteer in January.

New cancer fears in France over breast implants (Update)

March 17, 2015
France's national cancer institute said on Tuesday there was a "clearly established link" between a rare form of cancer and a certain type of breast implant, as the health minister sought to allay fears.

Vitamin K shots necessary to prevent internal bleeding in newborns

September 10, 2015
The growing trend of parents' shunning vaccines has crept into another area that has physicians recommending caution—forgoing vitamin K shots in newborns.

Breast implant scare: One in four found flawed

June 25, 2013
Doctors in France have removed PIP breast implants from more than 16,000 women and found a quarter of the scandal-tainted products had signs of splitting or leakage, a watchdog said on Tuesday.

France at odds with European medicines agency over Pill

January 11, 2013
France insisted Friday on restricting the prescription of newer-generation birth control pills even as Europe's medicines watchdog declared there was no evidence to merit a health warning.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.